New additions to the Science 37 executive team will enhance both the patient and sponsor experiences as well as extend patient recruitment and trial execution efficiencies  LOS ANGELES, January 14, 2020 — Science 37, the industry leader in decentralized clinical trials, recently announced that Jonathan Commons and Darcy Forman have joined the company as vice president of patient engagement and vice president of clinical operations, respectively. The additions help Science 37 extend its market-leading capabilities…

Executive role will significantly scale commercial operations and create unparalleled value for clients  LOS ANGELES, December 17, 2019 — Science 37, the industry leader in decentralized clinical trials, announced today that Steven Geffon has joined the company as its chief commercial officer. He will lead commercial operations and strategic partnerships.  Geffon joins Science 37 from Medrio, a leading SaaS data capture platform, where he was responsible for sales and marketing as chief commercial officer. Prior…

Organization extends its market leadership in the decentralized clinical trial industry LOS ANGELES, November 21, 2019 — Science 37, the industry leader in decentralized clinical trials, announced today that David Coman has joined the company as its chief executive officer. Coman joins Science 37 from ERT, a global data and technology company that helps minimize risk in clinical trials, where he led its data and analytics business after serving as the company’s chief strategy officer.…

The two organizations will compare care methods for treating patients with eczema LOS ANGELES, October 1, 2019 — Science 37, the industry leader in virtual clinical trials, and the Keck School of Medicine of the University of Southern California (USC) recently announced a partnership agreement that will support the execution of a $3.4 million study funded by the National Institutes of Health (NIH)—the largest telemedicine-based dermatology study ever funded by the organization. The new collaboration…

Ingelheim, Germany and Playa Vista, CA, USA , January 3, 2019 – Science 37, an industry leader in virtual clinical trials, and Boehringer Ingelheim announced today a technology enterprise collaboration agreement that will support Boehringer Ingelheim in running remote clinical trials. Science 37 is licensing access to its proprietary software platform, NORA® (Network Oriented Research Assistant), which leverages mobile technology and telemedicine capabilities, enabling patients to participate in clinical research studies regardless of their geographical…

Ingelheim, Germany and Playa Vista, CA, USA , January 3, 2019 – Science 37, an industry leader in virtual clinical trials, and Boehringer Ingelheim announced today a technology enterprise collaboration agreement that will support Boehringer Ingelheim in running remote clinical trials. Science 37 is licensing access to its proprietary software platform, NORA® (Network Oriented Research Assistant), which leverages mobile technology and telemedicine capabilities, enabling patients to participate in clinical research studies regardless of their geographical…

Science 37, a patient-centric clinical trial company announced today that Judy Smythe, MBA, Bardia Akbari, PharmD, and Niv Caviar, MBA have joined the company as their Chief Operating Officer, Senior Vice President of Clinical Operations, and Chief Financial Officer, respectively.